Arcus Revenue and Competitors

Location

N/A

Total Funding

Fintech

Industry

Estimated Revenue & Valuation

  • Arcus's estimated annual revenue is currently $17M per year.(i)
  • Arcus's estimated revenue per employee is $130,000

Employee Data

  • Arcus has 131 Employees.(i)
  • Arcus grew their employee count by -4% last year.

Arcus's People

NameTitleEmail/Phone
1
Business Development Head, VP at ArcusReveal Email/Phone
2
CSOReveal Email/Phone
3
Chief Operating OfficerReveal Email/Phone
4
Chief Operating OfficerReveal Email/Phone
5
QA DirectorReveal Email/Phone
6
Chief Technology OfficerReveal Email/Phone
7
Partnerships Director at ArcusReveal Email/Phone
8
Director People OperationsReveal Email/Phone
9
Product Design ManagerReveal Email/Phone
10
Software Engineer ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17M131-4%N/AN/A
#2
$96.6M3688%N/AN/A
#3
$24570M325205%$216M$209.6B
#4
$1770.7M952516%$2.3B$50B
#5
$5.5M47N/AN/AN/A
#6
$12.2M84-8%$145.3MN/A
#7
$12.5M96-9%$72.4MN/A
#8
$162.8M620N/AN/AN/A
#9
$1303.1M47136%$266M$20B
#10
$2007.1M11028N/AN/AN/A
#11
$165.6M89177%$529.3M$2.1B
#12
$3056.7M16795N/AN/AN/A
#13
$1490M5430N/AN/A$2.7B
#14
$20.4M1468%$81.1MN/A
#15
$40.2M174N/AN/AN/A
#16
$0.1M3N/AN/AN/A
#17
$1359.7M6698N/AN/AN/A
#18
$28.6M136N/AN/AN/A
#19
$27M189N/AN/AN/A
#20
$8.2M70N/AN/AN/A
Add Company

What Is Arcus?

Arcus is the best protocol for becoming the hub of your consumers financial health. Over 40 banks and fintech companies leverage our technology to facilitate their consumers' bill payments and management. Arcus launched in Y-Combinator in 2013 and its investors include Kapor Capital, Winklevoss Capital, Maverick Capital, Banco Itau and others.

keywords:Ventures for Good, Developer APIs, Mobile Payments, Emerging Markets

N/A

Total Funding

131

Number of Employees

$17M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Arcus News

2022-04-13 - Arcus Biosciences Announces New Employment Inducement ...

--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer...

2022-04-06 - Arcus Biosciences Shares Rise 12% After Addition to S&P SmallCap 600

By Chris Wack. Arcus Biosciences Inc. shares rose 12% to $39.15 after S&P Dow Jones Indices added it to the S&P SmallCap 600.

2022-03-30 - Arcus Biosciences gains 10% on addition to SmallCap 600

Arcus Biosciences (NYSE:RCUS) has jumped 9.7% postmarket on the news it's set to join the S&P SmallCap 600 index. It's moving in to replace...

2020-11-02 - Arcus Raises Funding from Citi Ventures

Arcus, a New York City-based Fintech-as-a-Service (FaaS) platform, received an investment of undisclosed amount from Citi Ventures. This investment will help facilitate the company’s growth in Mexico and to expand its biller network and facilitate consumer payments in the region. Led by Inigo ...

2020-11-02 - Fintech-As-A-Service Platform Arcus Secures Funding From Citi Ventures For Expansion & Partnerships in Latin America

Arcus, a Fintech-as-a-Service (FaaS) platform, announced on Monday it scored an investment from Citi Ventures for expansion and partnerships in Latin America. Arcus claims that this investment marks the first investment by Citi Ventures in a fintech company in Mexico. Founded in 2013, Arcus pro ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19M131-4%$89.8M
#2
$32.8M13141%N/A
#3
$18.3M131-5%N/A
#4
$29.7M131-6%N/A
#5
$32.8M131-24%N/A